Silver Book Fact

The combination of information for neuroimaging and circulatory biomarkers could improve both the sensitivity and specificity of pain diagnosis and thereby improve treatment.

Woolf C. Overcoming Obstacles to Developing New Analgesics. Nature Med. 2010; 16(11): 1241-7. http://www.nature.com/nm/journal/v16/n11/full/nm.2230.html

Reference

Title
Overcoming Obstacles to Developing New Analgesics
Publication
Nature Med
Publication Date
2010
Authors
Woolf C
Volume & Issue
Volume 16, Issue 11
Pages
1241-7
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Researchers have developed several sub-types of ion channels that allow inflammation and growth factors to trigger persistent pain.  
  • Use of stem cells to create neurons could enable the study of the response of human cells to new drugs in vitro, early in the drug development process.  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • People with persistent pain who used complementary and alternative medicine (CAM) had lower average health care expenditures than nonusers ($3,797 versus $4,153).  
  • Advances in neuroimaging will continue to offer information on the brain’s functioning and how it correlates to the pain experience.